Constance Therapeutics

San Francisco, United States Founded: 1996 • Age: 30 yrs
Cannabis-based therapeutics for various disease conditions are developed.

About Constance Therapeutics

Constance Therapeutics is a company based in San Francisco (United States) founded in 1996 by Constance Finley. Constance Therapeutics has raised $4.77 million across 3 funding rounds. Constance Therapeutics operates in a competitive market with competitors including ZYUS Life Sciences, Sanity Group, Terraflos, Avicanna and Little Green Pharma, among others.

  • Headquarter San Francisco, United States
  • Founders Constance Finley
  • Sectors
    Healthcare
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website constancetherapeutics.com
  • Social LinkedIn X Facebook
  • Legal Name Constance Therapeutics, Inc
Key Metrics
  • Total Equity Funding
    $4.77M (USD)

    in 3 rounds

  • Latest Funding Round
    $4.25M (USD), Unspecified

    Feb 2018

Funding Insights of Constance Therapeutics

Constance Therapeutics has successfully raised a total of $4.77M across 3 strategic funding rounds. The most recent funding activity was a Unspecified round of $4.25 million completed in February 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $4.77M
  • Total Rounds 3
  • Last Round Unspecified β€” $4.25M
  • First Round $26,650

    (Jun 2015)

All 3 funding rounds of Constance Therapeutics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Feb 2018$4.25MUnspecified––
–
Aug 2017$499,980Unspecified––
–
Jun 2015$26,650Unspecified––
–

People of Constance Therapeutics

1 people are tracked at Constance Therapeutics (1 in leadership).

NameRoleGroup
Constance Finley
Founder & CEOLeadership
Premium access

Complete people profiles for Constance Therapeutics

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Constance Therapeutics

3 dated milestones of Constance Therapeutics across 22 years, from founding to its latest funding, stage changes and deals.

  1. Founded Constance Therapeutics is founded.
  2. Funding First funding round of $27K.
  3. Funding Latest funding round, Unspecified, of $4.2M.

Competitors of Constance Therapeutics

Constance Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ZYUS Life Sciences, Sanity Group, Terraflos, Avicanna and Little Green Pharma, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
zyus.com2018Saskatoon, Canada$19.5M–
Cannabis-derived therapeutics for multiple indications are developed.
sanitygroup.com2011Berlin, Germany$108.79M–
Developer of cannabinoid-based pharmaceuticals and well-being products
terraflos.com2021Uruguay$8M–
Medical cannabis products are provided based on GMP processes.
avicanna.com2016Toronto, Canada$5.94M–
Plant-derived cannabinoid products are developed for medical and consumer uses.
littlegreenpharma.com2016Perth, Australia$1.91M–
Manufacturer of medicinal cannabis for therapeutic use
imcannabis.com2008Herzliya, Israel––
Developer of medical cannabis products
neocannbio.com2021Seoul, South Korea$10.9M–
Cannabinoid-based pharmaceuticals and production technologies are developed.
gleaf.com2014Frederick, United States$19.45M230
Medical cannabis is cultivated by gLeaf for dispensary supply.
Premium access

Detailed competitors of Constance Therapeutics

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Constance Therapeutics

Premium access

Complete news archive for Constance Therapeutics

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Similar companies to Constance Therapeutics

10 companies that operate in the same segment as Constance Therapeutics (Cannabis Health Tech Ecosystem), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Cannabis products are provided to support consumer wellness and health.
2013Smiths Falls, Ontario, Canada–USD 204.24 M960
Online marketplace platform for cannabis traders
2015New York, New York, United StatesUSD 195.4 M––
Loyalty and marketing solutions for cannabis dispensaries are provided.
2012West Palm Beach, Florida, United StatesUSD 25.79 MUSD 22.83 M–
An online marketplace for cannabis products is operated.
2017Bend, Oregon, United StatesUSD 603 M–137
Online platform for cannabis strains, reviews, and ratings
2010Seattle, Washington, United StatesUSD 40.7 M––
Provider of cannabis products, brands, and international business development investments
2013Moncton, New Brunswick, Canada–USD 186.16 M898
ERP software is offered via cloud platform for cannabis operations.
2018Boston, Massachusetts, United States–USD 110.08 M313
Online marketplace connecting licensed cannabis vendors and dispensaries
2015Chicago, Illinois, United StatesUSD 22.57 M––
Enterprise software is provided for cannabis dispensary management.
2016Oakland, California, United StatesUSD 75.5 MUSD 148.97 K97
Proprietary medical cannabis strains are developed and offered.
2014Maryland Heights, Missouri, United StatesUSD 156 M–557
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Constance Therapeutics

Constance Therapeutics was founded in 1996 and raised its 1st funding round 19 years after it was founded.

Constance Therapeutics is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.

Constance Finley is the current CEO of Constance Therapeutics. They have also founded this company.

Constance Therapeutics is a funded company, having raised a total of $4.77M across 3 funding rounds to date. The company's 1st funding round was a Unspecified of $26.65K, raised on Jun 2015.

Founded in 1996 in San Francisco, United States, cannabis-based therapeutics for treating various disease conditions are developed. Formulations incorporating a viscosity-reducing agent and organic essential oils are utilized to facilitate smoother inhalation and enhance the bioavailability of cannabinoids and terpenes. Products are offered in vape cartridges engineered to exclude solvents and harmful additives, supporting patient options in the medical cannabis sector.

Constance Therapeutics's top competitors include Avicanna, ZYUS Life Sciences and Neocannbio.

Constance Therapeutics operates through Constance Therapeutics, Inc.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available